
Retatrutide is a research peptide designed as a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. Its mechanism has made it a subject of scientific research involving metabolic mechanisms, energy balance, and receptor signaling.

An initial selection with clear specifications and visible prices.

Retatrutide is a research peptide designed as a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. Its mechanism has made it a subject of scientific research involving metabolic mechanisms, energy balance, and receptor signaling.

Retatrutide is a research peptide studied as a triple agonist of the GLP-1, GIP and glucagon receptors. Its receptor activity is of scientific interest in research into metabolic processes, energy balance and cellular signalling. Supplied in a vial containing 40 mg. For scientific and laboratory research only.

GLOW 80 mg is a combined research complex containing GHK-Cu 50 mg, TB-500 20 mg and BPC-157 10 mg, with declared ≥99% purity. For laboratory research only.

GHK-Cu 100 mg with ≥99% purity — a copper tripeptide complex intended for laboratory analysis and controlled scientific research. For research use only.

Bacteriostatic Water 10 mL with 0.9% benzyl alcohol, intended for the reconstitution and preparation of laboratory samples. For research use only.

Retatrutide is a research peptide designed as a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. Its mechanism has made it a subject of scientific research involving metabolic mechanisms, energy balance, and receptor signaling.